Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 104
interventional 73
Observational 29
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Biological 13
Drug 13
Drug|placebo 10
Other 8
Drug|Procedure 4
Procedure 4
Biological|Drug 3
Biological|placebo 3
Dietary Supplement 3
Behavioral 2
Device 2
Dietary Supplement|placebo 2
Biological|Dietary Supplement|placebo 1
Diagnostic Test 1
Dietary Supplement|Drug 1
Dietary Supplement|Other 1
Drug|Other|Procedure|Radiation 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 30
Spain 5
Brazil 3
China 3
Finland 3
France 3
NA 3
Canada 2
Russian Federation 2
Austria 1
Bangladesh 1
Belgium|Bulgaria|Germany 1
Czechia|Netherlands|Spain|Sweden 1
Denmark 1
Germany|Bulgaria|Belgium|Poland|Romania|Russian Federation|Spain 1
Greece 1
Jordan 1
Kenya 1
Mexico 1
Netherlands 1
Taiwan 1
Turkey 1
United Kingdom 1
United States|Argentina|Belgium|Brazil|Bulgaria|Canada|Chile|China|Germany|Israel|Italy|Latvia|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan 1
United States|Australia|Bulgaria|Canada|Chile|Czechia|Germany|Hungary|Italy|Japan|Korea, Republic of|Latvia|Mexico|Poland|Slovakia|Spain|Taiwan|United Kingdom 1
United States|Austria|Canada|France|Germany|Italy|Mexico|Spain|Sweden|United Kingdom 1
United States|Canada 1
United States|Canada|Denmark|Germany|United Kingdom 1

Sites per Study

Site_count Study_Count
1 46
2 9
4 2
5 4
8 1
13 1
18 1
19 1
21 2
27 1
36 1
45 1
82 1
216 1
242 1

Phase

Phase Study_Count
N/A 23
Phase 2 14
Phase 1 12
Phase 1/Phase 2 11
Phase 3 8
Phase 4 4
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 24
2 35
3 8
4 3
5 1
NA 2

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3 Phase.4
Min. 10 10.0000 6.00000 6 17.0000 48.0000 33.00
1st Qu. 10 37.0000 22.50000 24 42.7500 166.0000 45.75
Median 10 53.0000 34.00000 40 112.5000 251.0000 54.50
Mean 10 122.6522 36.08333 48 114.7857 431.7143 60.50
3rd Qu. 10 156.0000 52.25000 70 179.2500 584.0000 69.25
Max. 10 504.0000 64.00000 108 224.0000 1223.0000 100.00

Trial Group Type

group_type Group_Count
Experimental 86
Placebo Comparator 17
Active Comparator 13
No Intervention 10
Other 9
NA 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 37
Single Group Assignment 27
Sequential Assignment 5
Crossover Assignment 2
Factorial Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 49
Basic Science 6
Prevention 6
Diagnostic 3
Other 3
NA 3
Health Services Research 1
Screening 1
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
United States 15
France 4
China 2
Australia|New Zealand 1
Bangladesh 1
Canada 1
Denmark 1
Italy 1
NA 1
Poland 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 26
2 1
3 1
6 1

Enrollment Metrics

Measure Observational
Min 12.000
1st Qu 90.000
Median 241.000
Mean 3350.414
3rd Qu 800.000
Max 32658.000

Observation Model

observational_model Study_Count
Cohort 16
NA 5
Case-Control 4
Other 2
Case-Only 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 19
Cross-Sectional 4
NA 3
Retrospective 2
Other 1

Registries

Studies by Country

Country Study_Count
France 1
United States 1

Sites per Study

Site_count Study_Count
1 1
17 1

Enrollment Metrics

Measure Registries
Min 1500
1st Qu 1800
Median 2100
Mean 2100
3rd Qu 2400
Max 2700

Registry Model

observational_model Study_Count
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Cross-Sectional 1
Prospective 1

Follow-up

target_duration Study_Count
1 Year 2

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04458246 Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04458246 Recruiting University of Sao Paulo 2020-12-31
NCT03744676 A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007) https://ClinicalTrials.gov/show/NCT03744676 Recruiting Juno Therapeutics, a Subsidiary of Celgene 2022-11-30
NCT03373019 Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) https://ClinicalTrials.gov/show/NCT03373019 Recruiting Fudan University 2019-06-30
NCT03370627 Effect of Anti-CD303 Antibodies in Autoimmune Diseases https://ClinicalTrials.gov/show/NCT03370627 Recruiting University Hospital, Lille 2020-01-31
NCT03364699 Fish Oils and Soybean Lecithin Supplementation Modulate Immune Function in Runners https://ClinicalTrials.gov/show/NCT03364699 Completed University of Sao Paulo 2014-09-30
NCT03345004 GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes https://ClinicalTrials.gov/show/NCT03345004 Active, not recruiting Diamyd Medical AB 2020-08-31
NCT03337165 Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03337165 Completed Russian Academy of Medical Sciences 2019-05-31
NCT03332225 A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis https://ClinicalTrials.gov/show/NCT03332225 Active, not recruiting Hellenic Institute for the Study of Sepsis 2019-12-03
NCT03280797 Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases https://ClinicalTrials.gov/show/NCT03280797 Recruiting Centre Hospitalier Universitaire de NÄ«mes 2020-11-30
NCT03128996 Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders https://ClinicalTrials.gov/show/NCT03128996 Recruiting Washington University School of Medicine 2022-04-30
NCT03054428 Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03054428 Completed Regeneron Pharmaceuticals 2018-04-04
NCT03016377 Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL https://ClinicalTrials.gov/show/NCT03016377 Recruiting UNC Lineberger Comprehensive Cancer Center 2021-11-30
NCT02966301 Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide https://ClinicalTrials.gov/show/NCT02966301 Active, not recruiting Medsenic 2020-06-30
NCT02824393 Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria https://ClinicalTrials.gov/show/NCT02824393 Completed Celal Bayar University 2018-05-15
NCT02824237 GEOHealth Hub: Household Air Pollution and Cardio-pulmonary and Immune Function Outcomes https://ClinicalTrials.gov/show/NCT02824237 Recruiting International Centre for Diarrhoeal Disease Research, Bangladesh 2020-08-31
NCT02690545 Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL https://ClinicalTrials.gov/show/NCT02690545 Recruiting UNC Lineberger Comprehensive Cancer Center 2022-02-27
NCT02663297 Administration of T Lymphocytes for Prevention of Relapse of Lymphomas https://ClinicalTrials.gov/show/NCT02663297 Recruiting UNC Lineberger Comprehensive Cancer Center 2021-09-30
NCT02644759 Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT02644759 Completed Stem Cells Arabia 2017-08-31
NCT02630082 Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru https://ClinicalTrials.gov/show/NCT02630082 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2013-03-31
NCT02527187 Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa https://ClinicalTrials.gov/show/NCT02527187 Completed Inmunotek S.L. 2017-12-31
NCT02527122 Biological Stardadization of D. Pteronyssinus and D. Farinae Allergen Extracts https://ClinicalTrials.gov/show/NCT02527122 Completed Inmunotek S.L. 2018-07-31
NCT02519816 Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD https://ClinicalTrials.gov/show/NCT02519816 Active, not recruiting Maisonneuve-Rosemont Hospital 2020-01-01
NCT02449746 Study of Immunotherapy in Autoantibody Positive Psychosis https://ClinicalTrials.gov/show/NCT02449746 Completed University of Cambridge 2017-08-31
NCT02331446 The Effect of Different Volumes of Physical Exercise on the Immune System https://ClinicalTrials.gov/show/NCT02331446 Completed Federal University of Pelotas 2014-09-30
NCT02294552 Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT https://ClinicalTrials.gov/show/NCT02294552 Completed St. Petersburg State Pavlov Medical University 2016-11-30
NCT03385850 The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis https://ClinicalTrials.gov/show/NCT03385850 Completed Nanjing First Hospital, Nanjing Medical University 2018-06-30
NCT02210234 Wheat Bioactives and Immune Function https://ClinicalTrials.gov/show/NCT02210234 Completed University of Florida 2010-06-30
NCT02162576 Asthma Data Innovation Demonstration Project https://ClinicalTrials.gov/show/NCT02162576 Completed Reciprocal Labs 2014-01-31
NCT02119143 Micronutrient Supplementation and Incidence of Common Cold https://ClinicalTrials.gov/show/NCT02119143 Completed Green Beat 2017-01-31
NCT02053740 Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02053740 Completed Tri-Service General Hospital 2013-08-31
NCT01993732 Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function https://ClinicalTrials.gov/show/NCT01993732 Completed Medical College of Wisconsin 2018-06-28
NCT03351543 Effect of Microbial Exposure on Health, Particularly Immune System https://ClinicalTrials.gov/show/NCT03351543 Completed University of Helsinki 2016-06-30
NCT01821820 Pistachios, Performance, Metabolomics https://ClinicalTrials.gov/show/NCT01821820 Completed Appalachian State University 2014-06-30
NCT01775384 Polyphenols, Exercise, and Metabolomics https://ClinicalTrials.gov/show/NCT01775384 Completed Appalachian State University 2012-11-30
NCT01764594 Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01764594 Completed UCB Pharma 2014-08-31
NCT01727973 Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves’ Orbitopathy https://ClinicalTrials.gov/show/NCT01727973 Completed Sun Yat-sen University 2013-11-30
NCT01510626 Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center https://ClinicalTrials.gov/show/NCT01510626 Completed Stanford University 2014-04-30
NCT01490177 Single Center Food Allergy Oral Immunotherapy Study https://ClinicalTrials.gov/show/NCT01490177 Completed Stanford University 2014-04-30
NCT01472263 Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases https://ClinicalTrials.gov/show/NCT01472263 Completed Hospital Universitário Professor Edgard Santos 2012-09-30
NCT01441076 Anakinra for Behcet s Disease https://ClinicalTrials.gov/show/NCT01441076 Completed National Institutes of Health Clinical Center (CC) 2014-10-31
NCT01425073 Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya https://ClinicalTrials.gov/show/NCT01425073 Completed University of Washington 2013-10-31
NCT04319705 Anti-viral Effects of Azithromycin in Patients With Asthma and COPD https://ClinicalTrials.gov/show/NCT04319705 Recruiting Bispebjerg Hospital 2021-12-31
NCT04309084 Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma https://ClinicalTrials.gov/show/NCT04309084 Recruiting Celularity Incorporated 2023-03-12
NCT04294459 Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation https://ClinicalTrials.gov/show/NCT04294459 Recruiting Sanofi 2024-07-31
NCT04021303 Whole Grain, Gluten-containing Cereal and PROBIOtics to Evaluate Digestive TOLERAance and Immuno-inflammatory Response https://ClinicalTrials.gov/show/NCT04021303 Recruiting Laboratorios Ordesa 2021-06-30
NCT03997175 Effect of Modified Playground Environment on Health, Particularly Immune System https://ClinicalTrials.gov/show/NCT03997175 Completed University of Helsinki 2018-07-30
NCT03908736 Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation https://ClinicalTrials.gov/show/NCT03908736 Recruiting University of New Mexico 2022-04-30
NCT03856879 High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults https://ClinicalTrials.gov/show/NCT03856879 Recruiting Seattle Institute for Biomedical and Clinical Research 2022-12-31
NCT03720470 Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy https://ClinicalTrials.gov/show/NCT03720470 Completed Pfizer 2019-12-27
NCT03696784 Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma https://ClinicalTrials.gov/show/NCT03696784 Recruiting UNC Lineberger Comprehensive Cancer Center 2023-10-12
NCT03688074 Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) https://ClinicalTrials.gov/show/NCT03688074 Active, not recruiting AstraZeneca 2020-09-16
NCT03672318 Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma https://ClinicalTrials.gov/show/NCT03672318 Recruiting UNC Lineberger Comprehensive Cancer Center 2020-11-30
NCT03663933 Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation https://ClinicalTrials.gov/show/NCT03663933 Recruiting National Institutes of Health Clinical Center (CC) 2023-05-27
NCT03627767 Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects https://ClinicalTrials.gov/show/NCT03627767 Active, not recruiting Pfizer 2020-08-27
NCT03602157 Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL https://ClinicalTrials.gov/show/NCT03602157 Recruiting UNC Lineberger Comprehensive Cancer Center 2026-09-30
NCT03578341 Oral Colostrum and Its Effect on Immune System https://ClinicalTrials.gov/show/NCT03578341 Active, not recruiting Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 2019-10-30
NCT03563066 Effect of Benralizumab in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03563066 Recruiting McMaster University 2019-07-31
NCT01222039 Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease. https://ClinicalTrials.gov/show/NCT01222039 Completed Andalusian Network for Design and Translation of Advanced Therapies 2014-06-30
NCT01093911 Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01093911 Completed UCB Pharma 2012-12-31
NCT01090102 Mesalamine to Reduce T Cell Activation in HIV Infection https://ClinicalTrials.gov/show/NCT01090102 Completed University of California, San Francisco 2012-12-31
NCT01056471 Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis https://ClinicalTrials.gov/show/NCT01056471 Completed Andalusian Network for Design and Translation of Advanced Therapies 2012-06-30
NCT01002742 Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) https://ClinicalTrials.gov/show/NCT01002742 Completed Medical College of Wisconsin 2012-01-31
NCT03922724 Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma https://ClinicalTrials.gov/show/NCT03922724 Recruiting National Institutes of Health Clinical Center (CC) 2023-05-27
NCT04365101 Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) https://ClinicalTrials.gov/show/NCT04365101 Recruiting Celularity Incorporated 2020-11-30
NCT03161288 A Study of KY1005 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03161288 Completed Kymab Limited 2018-03-30
NCT02640014 Oral Immunotherapy in Food Allergy in Finland https://ClinicalTrials.gov/show/NCT02640014 Active, not recruiting Helsinki University Central Hospital 2020-12-31
NCT02579967 Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies https://ClinicalTrials.gov/show/NCT02579967 Recruiting National Institutes of Health Clinical Center (CC) 2022-12-21
NCT00224874 Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) https://ClinicalTrials.gov/show/NCT00224874 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-01-31
NCT00119548 Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling https://ClinicalTrials.gov/show/NCT00119548 Completed VA Office of Research and Development 2007-01-31
NCT00035308 Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease https://ClinicalTrials.gov/show/NCT00035308 Completed La Jolla Pharmaceutical Company NA
NCT00023504 Antibody Production in Immune Disorders https://ClinicalTrials.gov/show/NCT00023504 Recruiting National Institutes of Health Clinical Center (CC) 2026-09-19
NCT00008450 Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00008450 Completed Fred Hutchinson Cancer Research Center 2011-10-25
NCT00000591 T-Cell Depletion in Unrelated Donor Marrow Transplantation https://ClinicalTrials.gov/show/NCT00000591 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03780712 Immune Dysfunction in Newborn Sepsis https://ClinicalTrials.gov/show/NCT03780712 Completed BioMérieux 2018-03-12
NCT03300830 Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease https://ClinicalTrials.gov/show/NCT03300830 Recruiting National Institutes of Health Clinical Center (CC) 2037-06-07
NCT03225950 Interaction Between Immune Cells and Bacteria Associated With Periodontitis https://ClinicalTrials.gov/show/NCT03225950 Completed University of Copenhagen 2018-10-12
NCT03207854 Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers https://ClinicalTrials.gov/show/NCT03207854 Recruiting University of Southern California 2022-04-12
NCT02981992 T Regulatory Cells in Hemodialysis Patients: Observational Study https://ClinicalTrials.gov/show/NCT02981992 Completed IRCCS Policlinico S. Matteo 2014-02-28
NCT02916888 A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists https://ClinicalTrials.gov/show/NCT02916888 Completed Yale University 2017-12-31
NCT02417766 NIAID Clinical Center Genomics Opportunity Protocol https://ClinicalTrials.gov/show/NCT02417766 Completed National Institutes of Health Clinical Center (CC) 2019-01-22
NCT01917760 Pharmacokinetics Study of Gamma-aminobutyric Acid https://ClinicalTrials.gov/show/NCT01917760 Completed Huashan Hospital 2014-07-31
NCT01328548 Zoster Vaccine Response in the Frail Elderly https://ClinicalTrials.gov/show/NCT01328548 Completed McMaster University 2015-03-31
NCT04386395 Immune Changes in Severe COVID-19 Pulmonary Infections https://ClinicalTrials.gov/show/NCT04386395 Active, not recruiting Central Hospital, Nancy, France 2020-05-01
NCT04103099 Impact of HLNatural Immune Supplement on Colds https://ClinicalTrials.gov/show/NCT04103099 Recruiting Hawthorne Effect Inc. 2020-08-15
NCT04026815 Health Status and Its Socio-economic Covariates of the Older Population in Poland - the Nationwide PolSenior2 Survey. https://ClinicalTrials.gov/show/NCT04026815 Recruiting Medical University of Gdansk 2019-12-31
NCT03930017 Pregnancy, Arsenic and Immune Response https://ClinicalTrials.gov/show/NCT03930017 Enrolling by invitation Johns Hopkins Bloomberg School of Public Health 2020-02-28
NCT03922087 No-worry Baby Project https://ClinicalTrials.gov/show/NCT03922087 Recruiting Sun Yat-sen University 2021-12-31
NCT03901664 Lymphocyte Sub-populations and Auto Immune Diseases https://ClinicalTrials.gov/show/NCT03901664 Completed University Hospital, Brest 2018-04-01
NCT03503747 Investigating Genetic Risk for Type 1 Diabetes https://ClinicalTrials.gov/show/NCT03503747 Recruiting University of Oxford 2021-02-28
NCT01161056 Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways https://ClinicalTrials.gov/show/NCT01161056 Completed Northwell Health 2015-04-30
NCT00968084 Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols https://ClinicalTrials.gov/show/NCT00968084 Completed National Institutes of Health Clinical Center (CC) NA
NCT00960713 The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders https://ClinicalTrials.gov/show/NCT00960713 Completed University Hospital, Toulouse 2012-01-31
NCT03815357 What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)? https://ClinicalTrials.gov/show/NCT03815357 Recruiting Murdoch Childrens Research Institute 2021-01-31
NCT02855840 Auto-immune Diseases and Quality of Life https://ClinicalTrials.gov/show/NCT02855840 Completed Centre Hospitalier Universitaire Dijon 2016-03-31
NCT00001467 Genetic Analysis of Immune Disorders https://ClinicalTrials.gov/show/NCT00001467 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT00006150 Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection https://ClinicalTrials.gov/show/NCT00006150 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01287000 Gulf Long-Term Follow-Up Study https://ClinicalTrials.gov/show/NCT01287000 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT03562975 Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus https://ClinicalTrials.gov/show/NCT03562975 Recruiting University of South Florida 2020-08-31
NCT00575315 HIV-HCV Coinfection: Impact of Immune Dysfunction https://ClinicalTrials.gov/show/NCT00575315 Completed Virginia Commonwealth University 2014-08-31
NCT00113464 Developing Newborn Screening for Infants With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT00113464 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001659 Consequences of Conjugal Bereavement in Adults https://ClinicalTrials.gov/show/NCT00001659 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001406 Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia https://ClinicalTrials.gov/show/NCT00001406 Recruiting National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04445402 Pediatrics HOT COVID-19 Database in NY Tristate https://ClinicalTrials.gov/show/NCT04445402 Recruiting Columbia University 2021-05-01
NCT03994302 Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) https://ClinicalTrials.gov/show/NCT03994302 Recruiting Groupe Hospitalier Pitie-Salpetriere 2021-06-30